Immunobrain Checkpoint, Inc

Website
200 E 61st St Apt 38F
New York, NY 10065

Immunobrain Checkpoint, Inc is a pioneering company based in New York, NY, dedicated to transforming the understanding and treatment of neurodegeneration. They are redefining the treatment of neurological disorders by leveraging the body's own defense mechanisms and harnessing the power of the peripheral immune system to mitigate brain pathology.

With a focus on Alzheimer's disease, Immunobrain Checkpoint is currently investigating their lead program IBC-Ab002, a novel anti-PD-L1 antibody, in patients with early-stage Alzheimer's disease. They are building upon their unique understanding of how the peripheral immune system communicates with the brain, targeting it to benefit brain health.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkNew YorkImmunobrain Checkpoint, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.